Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma

作者: Yao Liang , Wei Xiao , Yuan-Xiang Guan , Wei Wang , Huo Ying Chen

DOI: 10.18632/ONCOTARGET.20990

关键词:

摘要: // Yao Liang 1, * , Wei Xiao Yuan-Xiang Guan Wang 1 Huo Ying Chen Cheng Fang Xing Zhang and Zhi-Wei Zhou Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Medicine, Guangzhou 510060, People’s Republic China Co-first authors Correspondence to: Zhou, email: zhouzhw@sysucc.org.cn Zhang, zhangxing@sysucc.org.cn Keywords: C-reactive protein; albumin; inflammation-based prognostic factors; soft tissue sarcoma; prognosis Received: July 19, 2017     Accepted: August 17, Published: September 18, 2017 ABSTRACT Background: The preoperative protein/Albumin ratio (CAR) is valuable predicting the patients with various types cancers. aim present study to investigate value CAR compare it other systemic inflammatory response markers sarcoma (STS). Methods: This retrospective included 206 STS. optimal cutoff was determined by receiver operating characteristic (ROC) analysis. impact clinicopathological features on overall survival (OS) disease-free (DFS) evaluated using univariate multivariate Cox regression analyses. Kaplan-Meier analyses were used groups classified CAR. Additionally, area under curve (AUC) predictive ability CAR, high-sensitivity modified Glasgow score (Hs-mGPS), neutrophil-lymphocyte (NLR) platelet-lymphocyte (PLR). Results: cut-off 0.1035 according ROC An increased (≥0.1035) significantly associated older age, larger tumor size, deep location, higher grade more advanced American Joint Committee (AJCC) stage (all P<0.05). Patients an elevated exhibited a shorter median time lower 5-year OS rate than those CAR<0.1035 (68.2 vs 115.8 months, P = 0.000; 44.6% 80.9%, 0.000, respectively). results analysis indicated that (Hazard (HR) 2.47, 95% confidence interval (CI) 1.47-4.14, 0.001) independent factor along (P<0.05). greater AUC (0.662) NLR PLR, but equal Hs-mGPS. Conclusions: STS exhibits superior compared established indices.

参考文章(30)
N. Iqbal, N. K. Shukla, S. V. S. Deo, S. Agarwala, D. N. Sharma, M. C. Sharma, S. Bakhshi, Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients Clinical and Translational Oncology. ,vol. 18, pp. 310- 316 ,(2016) , 10.1007/S12094-015-1369-9
Tomoki Nakamura, Akihiko Matsumine, Takao Matsubara, Kunihiro Asanuma, Astumasa Uchida, Akihiro Sudo, Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma. Cancer. ,vol. 118, pp. 1055- 1061 ,(2012) , 10.1002/CNCR.26353
Shubham Pant, Ludmila K. Martin, Susan Geyer, Lai Wei, Katherine Van Loon, Nilli Sommovilla, Mark Zalupski, Renuka Iyer, David Fogelman, Andrew H. Ko, Tanios Bekaii-Saab, Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: a pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab. Cancer. ,vol. 120, pp. 1780- 1786 ,(2014) , 10.1002/CNCR.28648
C-H Koh, N Bhoo-Pathy, K-L Ng, R S Jabir, G-H Tan, M-H See, S Jamaris, N A Taib, Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer British Journal of Cancer. ,vol. 113, pp. 150- 158 ,(2015) , 10.1038/BJC.2015.183
Michael J. Proctor, Paul G. Horgan, Dinesh Talwar, Colin D. Fletcher, David S. Morrison, Donald C. McMillan, Optimization of the systemic inflammation‐based Glasgow Prognostic Score Cancer. ,vol. 119, pp. 2325- 2332 ,(2013) , 10.1002/CNCR.28018
Xuechao Liu, Xiaowei Sun, Jianjun Liu, Pengfei Kong, Shangxiang Chen, Youqing Zhan, Dazhi Xu, Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer Translational Oncology. ,vol. 8, pp. 339- 345 ,(2015) , 10.1016/J.TRANON.2015.06.006
Lisa M. Coussens, Zena Werb, Inflammation and cancer Nature. ,vol. 420, pp. 860- 867 ,(2002) , 10.1038/NATURE01322
Agnes Neuville, Frédéric Chibon, Jean-Michel Coindre, Grading of soft tissue sarcomas: from histological to molecular assessment Pathology. ,vol. 46, pp. 113- 120 ,(2014) , 10.1097/PAT.0000000000000048
Stephen B. Edge, Carolyn C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM Annals of Surgical Oncology. ,vol. 17, pp. 1471- 1474 ,(2010) , 10.1245/S10434-010-0985-4
Vickie Y. Jo, Christopher D.M. Fletcher, WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. ,vol. 46, pp. 95- 104 ,(2014) , 10.1097/PAT.0000000000000050